# Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns

> **NCT04262648** · NA · COMPLETED · sponsor: **NovoNatum Ltd** · enrollment: 90 (actual)

## Conditions studied

- Infantile Colic
- Constipation
- Infantile Diarrhea
- Gastro Esophageal Reflux

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus Reuteri
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04262648
- **Lead sponsor:** NovoNatum Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-03
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04262648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04262648, "Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04262648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*